| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/13/2003 | US20030049748 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders |
| 03/13/2003 | US20030049747 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2003 | US20030049746 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders |
| 03/13/2003 | US20030049745 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders |
| 03/13/2003 | US20030049744 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders |
| 03/13/2003 | US20030049743 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders |
| 03/13/2003 | US20030049742 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative, nervous system and tumor disorders |
| 03/13/2003 | US20030049741 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2003 | US20030049740 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative, nervous system and tumor disorders |
| 03/13/2003 | US20030049739 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2003 | US20030049738 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2003 | US20030049735 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2003 | US20030049734 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2003 | US20030049733 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative, tumor, nervous system, arthritis, graft-versus-host disease, stroke, psoriasis and inflammatory bowel disease |
| 03/13/2003 | US20030049732 Apoptosis related polynucleotides, polypeptides, and antibodies |
| 03/13/2003 | US20030049730 ABCG5 and ABCG8: compositions and methods of use |
| 03/13/2003 | US20030049728 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof |
| 03/13/2003 | US20030049727 Nucleotide sequences coding polypeptide for use in the treatment of epilepsy and nervous system disorders |
| 03/13/2003 | US20030049726 Polypeptide for use in the treatment of metabolic disorders |
| 03/13/2003 | US20030049724 52906, 33408, and 12189, novel potassium channel family members and uses thereof |
| 03/13/2003 | US20030049723 MAGE-A3 peptides presented by HLA class II molecules |
| 03/13/2003 | US20030049715 Peptide biomarker and method of identification |
| 03/13/2003 | US20030049709 Modulating apoptosis in cells; obtain cell sample, incubate with caspase, monitor apoptotic activity in cells, adustment in activity indicates modulator |
| 03/13/2003 | US20030049702 Polypeptide for use in the diagnosis and treatment of chlymadia infections |
| 03/13/2003 | US20030049699 Polypeptide for use in the treatment of cell proliferation disorders |
| 03/13/2003 | US20030049697 Detection of potassium channel modulators for treatment of heart, vascular and endrocrine pathologies; obtain sample, incubate with modulator, monitor effect of modulator on transport protein activity |
| 03/13/2003 | US20030049694 Production of fusion proteins and use for identifying binding molecules |
| 03/13/2003 | US20030049691 Nucleotide sequences coding polypeptide for use as diagnostic tool in the detection of allergic response to mammalian animal dander |
| 03/13/2003 | US20030049690 Detection of DNA damaging agents |
| 03/13/2003 | US20030049688 Protein fragment complementation assays for the detection of biological or drug interactions |
| 03/13/2003 | US20030049686 Generation of mutant protein library; obtain nucleotide sequences coding mutant proteins, incubate with cells, transform cells, recover transformed cells, propagate, recover cloned sequences coding mutant protein |
| 03/13/2003 | US20030049685 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 03/13/2003 | US20030049684 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 03/13/2003 | US20030049683 Rationally designed antibodies |
| 03/13/2003 | US20030049682 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 03/13/2003 | US20030049681 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2003 | US20030049677 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2003 | US20030049676 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 03/13/2003 | US20030049672 Modulation of protein binding; obtain sample containing polypeptides, incubate with modulator, detect adjustment in protein activity |
| 03/13/2003 | US20030049669 Protein for use in detection of bacterial infections |
| 03/13/2003 | US20030049664 87144, human amino acid transporter family member and uses therefor |
| 03/13/2003 | US20030049661 Proteins for use in the treatment and diagnosis of brain and nervous system disorders |
| 03/13/2003 | US20030049651 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer |
| 03/13/2003 | US20030049650 Nucleic acids, proteins, and antibodies |
| 03/13/2003 | US20030049649 Targeted modification of chromatin structure |
| 03/13/2003 | US20030049648 37 staphylococcus aureus genes and polypeptides |
| 03/13/2003 | US20030049646 Nucleotide sequences coding polypeptide for use in the treatment of arrhythmias, hypertension, angina, asthma, diabetes, kidney deffects, urinary, cerebral and autoimmune diseases |
| 03/13/2003 | US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders |
| 03/13/2003 | US20030049641 Detection of immunosuppressive agent; obtain tissue, incubate with modulator, monitor sample for nuclear translocation, nuclear translocation indicates presence of modulator |
| 03/13/2003 | US20030049640 Proteins, genes and their use for diagnosis and treatment of vascular response |
| 03/13/2003 | US20030049638 Nucleotide sequences coding polypeptide for use in the treatment and prevention of cell proliferative, nervous system and tumor disorders |
| 03/13/2003 | US20030049633 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2003 | US20030049623 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer |
| 03/13/2003 | US20030049622 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2003 | US20030049621 Secreted and transmembrane polypeptides and nucleic acids enconding the same |
| 03/13/2003 | US20030049611 Pentamer peptide amide, algpgnh2, which inhibits viral infectivity and methods of use thereof |
| 03/13/2003 | US20030049609 Viral proteins capable of binding LAR |
| 03/13/2003 | US20030049607 Protein complex for use in controlling viral propagation in cells |
| 03/13/2003 | US20030049606 Novel anti-viral and anti-proliferative agents derived from STAT1 transcription factor |
| 03/13/2003 | US20030049605 Display of viral proteins |
| 03/13/2003 | US20030049604 Viral proteins for use in the treatment and prevention of infection and viral diseases |
| 03/13/2003 | US20030049603 Designing preferential chemokines; obtain phage display library, incubate with cells, harvest cells, release phage, incubate with bacteria and clone phage, recover clones |
| 03/13/2003 | US20030049601 Detecting hepatitis in sample; obtain sample, incubate with binding agent, detect complex, presence of complex indicate hepatitis virus |
| 03/13/2003 | US20030049600 Kits for use in the detection of virus in sample |
| 03/13/2003 | US20030049339 Nucleic acid encoding a lectin derived progenitor cell preservation factor |
| 03/13/2003 | US20030049278 Transmission blocking vaccine against malaria |
| 03/13/2003 | US20030049274 PRRSV vaccines |
| 03/13/2003 | US20030049273 Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin |
| 03/13/2003 | US20030049271 Diagnosis, therapy of bacteria infections |
| 03/13/2003 | US20030049269 Mycobacterium tuberculosis DNA sequences encoding immunostimulatory peptides and methods for using same |
| 03/13/2003 | US20030049265 Heliobacter pylori antigen |
| 03/13/2003 | US20030049264 Releasing neurotransmitters; analgesics |
| 03/13/2003 | US20030049263 Vaccine; nucleotide sequences |
| 03/13/2003 | US20030049259 Control of lymphocyte localization by LEEP-CAM activity |
| 03/13/2003 | US20030049258 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle |
| 03/13/2003 | US20030049248 Netrins |
| 03/13/2003 | US20030049246 Prevent cell differentiation of nerve cells |
| 03/13/2003 | US20030049243 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 03/13/2003 | US20030049239 Antitumor agents, anticancer agent |
| 03/13/2003 | US20030049237 Isolated nucleic acids; prevent binding of antigens; peanut allergies |
| 03/13/2003 | US20030049229 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes |
| 03/13/2003 | DE3890874C2 Rekombinante Viren Recombinant viruses |
| 03/13/2003 | DE20121564U1 Composition useful for treating respiratory disease, comprises a peptide that activates guanylate cyclase C, and is delivered to the apical membrane through the respiratory tract |
| 03/13/2003 | CA2497222A1 Methods to increase the productivity of meterologous gene expression |
| 03/13/2003 | CA2477811A1 Chicken anemia virus vaccine from cell line |
| 03/13/2003 | CA2459937A1 Ncam binding compounds |
| 03/13/2003 | CA2459816A1 Hybrid and tandem expression of neisserial proteins |
| 03/13/2003 | CA2459777A1 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof |
| 03/13/2003 | CA2459728A1 Late gestation lung genes, fragments and uses thereof |
| 03/13/2003 | CA2459517A1 Human schizophrenia gene |
| 03/13/2003 | CA2459348A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 03/13/2003 | CA2459272A1 Novel serine protease inhibitory protein mt0039 |
| 03/13/2003 | CA2459138A1 Modified human growth hormone |
| 03/13/2003 | CA2459136A1 A caspase-8 binding protein, its preparation and use |
| 03/13/2003 | CA2459079A1 Plant-derived resistance gene |
| 03/13/2003 | CA2459077A1 Diagnosis of carcinomas |
| 03/13/2003 | CA2458995A1 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 03/13/2003 | CA2458968A1 Method for classification of anti-psychotic drugs |
| 03/13/2003 | CA2458953A1 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation |
| 03/13/2003 | CA2458915A1 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |